WARSAW, Ind., June 7, 2021 /PRNewswire/ -- Zimmer Biomet
Holdings, Inc. (NYSE and SIX: ZBH), a global leader in
musculoskeletal healthcare, today announced two new appointments to
the Company's Executive Leadership Team. Wilfred van Zuilen has been appointed as
President of Europe, Middle East and Africa (EMEA). Additionally, Nitin Goyal, M.D. has been appointed to the
newly created role of Chief Science, Technology and Innovation
Officer. Both roles will report into Chief Operating Officer
Ivan Tornos.
"It is an exciting time at Zimmer Biomet as we continue to build
out our Executive Team to ensure we have the proven, strategic
leadership in place to guide us through the third phase of our
business transformation," said Bryan
Hanson, Chairman, President and CEO of Zimmer Biomet. "As an
organization, we remain focused on developing our people, placing
the right team members in the right roles and providing the tools
and support needed to execute and drive our performance."
Wilfred van Zuilen as
President, Europe, Middle East and Africa
Mr. van Zuilen will be responsible for the marketing, sales and
distribution of products, services and solutions in the EMEA
region. Prior to joining Zimmer Biomet, Mr. van Zuilen served as
Regional Vice President, North Western Europe (United Kingdom, Ireland, Nordics and Benelux) at Medtronic.
Prior to that, he led Medtronic's Restorative Therapies Group of
businesses for EMEA and has also held regional leadership positions
with Covidien, Novartis and Edwards Lifesciences.
"We're thrilled to have Wilfred join the Zimmer Biomet team to
help advance our Mission and drive forward our business in the EMEA
region," said Mr. Tornos. "His experience in med tech,
coupled with his deep knowledge of the EMEA region's business
needs, make him the ideal candidate for this role."
Mr. van Zuilen holds a bachelor's degree in Business Economics
from Erasmus University in Rotterdam.
Nitin Goyal, M.D. as Chief
Science, Technology and Innovation Officer
In his newly created role, Dr. Goyal will oversee advanced
research, product development, and Zimmer Biomet's innovation
platforms. In addition, he will have oversight of Medical
Education, Clinical Affairs and healthcare provider collaboration.
Dr. Goyal is a practicing hip and knee reconstruction surgeon.
Prior to joining Zimmer Biomet, he also served as Chief Medical
Officer and Senior Vice President of Innovation and Digital Care
Delivery at Rally Health, part of the Optum business of
UnitedHealth Group.
"Dr. Goyal joins the Zimmer Biomet team at a time when we're
advancing our portfolio of seamlessly connected digital health and
robotic technologies that are designed to deliver data-powered
clinical insights throughout the surgical journey," said Mr.
Tornos. "His clinical experience and expertise in the digital
transformation of musculoskeletal care make up the perfect skillset
to help drive forward our business at this vital time in the
Company's transformation."
Dr. Goyal is the Founder and CEO of Pulse Platform as well as
Surgical Creations, leading both companies from inception to
acquisition. He received his Bachelor's degree from Penn State University, his Medical degree from the
Jefferson Medical College and completed his residency in Orthopedic
Surgery and fellowship in Adult Reconstruction at the Rothman
Institute and Thomas Jefferson
University Hospital in Philadelphia, Pennsylvania.
About the Company
Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer Biomet is a global leader in
musculoskeletal healthcare. We design, manufacture and market
orthopedic reconstructive products; sports medicine, biologics,
extremities and trauma products; office-based technologies; spine,
craniomaxillofacial and thoracic products; dental implants; and
related surgical products.
We collaborate with healthcare professionals around the globe to
advance the pace of innovation. Our products and solutions
help treat patients suffering from disorders of, or injuries to,
bones, joints or supporting soft tissues. Together with
healthcare professionals, we help millions of people live better
lives.
We have operations in more than 25 countries around the world
and sell products in more than 100 countries. For more
information, visit www.zimmerbiomet.com or follow Zimmer
Biomet on Twitter at www.twitter.com/zimmerbiomet.
Cautionary Statement Regarding Forward-Looking
Statements
This news release contains forward-looking statements within
the meaning of the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995. Forward-looking statements include,
but are not limited to, statements concerning Zimmer Biomet's
expectations, plans, prospects, and product and service offerings,
including new product launches and potential clinical successes.
Such statements are based upon the current beliefs and expectations
of management and are subject to significant risks, uncertainties
and changes in circumstances that could cause actual outcomes and
results to differ materially. For a list and description of some of
such risks and uncertainties, see Zimmer Biomet's periodic reports
filed with the U.S. Securities and Exchange Commission (SEC). These
factors should not be construed as exhaustive and should be read in
conjunction with the other cautionary statements that are included
in Zimmer Biomet's filings with the SEC. Forward-looking statements
speak only as of the date they are made, and Zimmer Biomet
disclaims any intention or obligation to update or revise any
forward-looking statements, whether as a result of new information,
future events or otherwise. Readers of this news release are
cautioned not to rely on these forward-looking statements, since
there can be no assurance that these forward-looking statements
will prove to be accurate. This cautionary statement is applicable
to all forward-looking statements contained in this news
release.
ZBH-Corp
Contacts:
|
|
|
|
Media
|
|
Meredith
Weissman
|
|
(703)
346-3127
|
|
meredith.weissman@zimmerbiomet.com
|
|
|
|
Investors
|
|
Ezgi Yagci
|
Keri
Mattox
|
(617)
549-2443
|
(203)
399-0856
|
ezgi.yagci@zimmerbiomet.com
|
keri.mattox@zimmerbiomet.com
|
View original content to download
multimedia:http://www.prnewswire.com/news-releases/zimmer-biomet-announces-new-appointments-to-executive-leadership-team-301306731.html
SOURCE Zimmer Biomet Holdings, Inc.